DNAprint Genomics (DNAG)

[easymedicine]

good and bad of technical aspects for DNAP..........

The 60 minute chart lends two continuing circumstance: more negative volume (systematic shorting or distribution of new shares); and violation of the trading range to the bull side.



The weekly chart, stilll not having completed the current print for this week, suggests new share distributions are underway. Lavander verticle lines highlight recent weeks of similar activity. Note these occur during the highest volume periods, brief upward price thrusts, and since Dutchess has become a financial partner of DNAP.



These charts all offer print of single divergence and trend divergence in volume studies. This is indicative of systematic shorting or new share distributions. Seeing price is no longer in a downward near term trend, shorting appears unlikely. New share distributions are ongoing in very strong likelihood. These events nearly always occur in upward trending markets.

While the trend may be obvious, trends seldom travel in one direction for long. If new share distributions are being realized, and I strongly believe they are, it presents a problem for both traders and investors: At some point the activity will cease and participating volume will be on the opposite side of the trend. Unfortunately, this can occur at any moment. It is all dependent of the guy behind the curtain. At the flip of a switch the current price appreciation can stop and the real market resume.

All said, it appears DNAP will retest recent relative highs for the near term (in the least).

Good luck